Jacob L van Dam
12PUBLICATIONS
67CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (12)
Sort by Publication Date:
|Jan 29, 2026
Thromboembolic Events During Perioperative Therapy for Resectable and Borderline Resectable Pancreatic Cancer in the PREOPANC-2 Trial.Ruth A L Willems, Aniek E van Diepen, Esther N Dekker
|Dec 01, 2025
Delayed gastric emptying after pancreatic cancer surgery impacts time to start of adjuvant treatment but not overall survival: a post-hoc analysis of the PREOPANC-1 and -2 trials.Bo T M Strijbos, Imme Kraakman, Jana S Hopstaken
|May 06, 2025
Survival after neoadjuvant and induction FOLFIRINOX versus gemcitabine-nab-paclitaxel in patients with resected localised pancreatic adenocarcinoma: an international multicentre study.Thomas F Stoop, Y H Andrew Wu, Atsushi Oba
|Feb 05, 2024
Improved Clinical Staging System for Localized Pancreatic Cancer Using the ABC Factors: A TAPS Consortium Study.Esther N Dekker, Jacob L van Dam, Quisette P Janssen
|Jul 13, 2023
Predictive value of baseline serum carbohydrate antigen 19-9 level on treatment effect of neoadjuvant chemoradiotherapy in patients with resectable and borderline resectable pancreatic cancer in two randomized trials.Deesje Doppenberg, Jacob L van Dam, Youngmin Han
|Jul 18, 2022
Treatment Response and Conditional Survival in Advanced Pancreatic Cancer Patients Treated with FOLFIRINOX: A Multicenter Cohort Study.Fleur van der Sijde, Jacob L van Dam, Bas Groot Koerkamp
Pageof 2
Frequent Collaborators
9 joint publications
Bas Groot Koerkamp
8 joint publications
Marc G Besselink
4 joint publications
Olivier R Busch
4 joint publications
Judith de Vos-Geelen
3 joint publications
Casper H J van Eijck
2 joint publications
Bert A Bonsing
2 joint publications
Ching-Wei D Tzeng
2 joint publications
Jin He
2 joint publications
Alice C Wei
2 joint publications
Eva Versteijne
